Luca Bertamini

6PUBLICATIONS
70CO-AUTHORS
Haematological tumoursPredictive and prognostic markersMedical biochemistry - nucleic acidsCardiology (incl. cardiovascular diseases)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Sep 01, 2026
Spatial profiling identifies a distinct and topographically-defined tumor microenvironment that emerges during multiple myeloma evolution.

|Dec 18, 2025
Circulating tumor cells in myeloma are a compound biomarker for bone marrow high-risk genomic alterations and tumor load.

Cathelijne Fokkema, Luca Bertamini, Madelon M E de Jong

|Oct 08, 2025
Circulating tumor cells predict myeloma outcomes in patients treated with daratumumab, bortezomib, lenalidomide, and dexamethasone.

Luca Bertamini, Cathelijne Fokkema, Paula Rodriguez-Otero

|Nov 21, 2024
Serum free light chains in a racially diverse population including African Americans and populations from South Africa.

Luca Bertamini, Jean-Baptiste Alberge, David J Lee

|Oct 26, 2024
Clonal hematopoiesis in cardiovascular aging: Insights from the verona heart study.

Katarzyna Malgorzata Kwiatkowska, Nicola Martinelli, Luca Bertamini

|Jun 06, 2022
High Levels of Circulating Tumor Plasma Cells as a Key Hallmark of Aggressive Disease in Transplant-Eligible Patients With Newly Diagnosed Multiple Myeloma.

Luca Bertamini, Stefania Oliva, Delia Rota-Scalabrini

Pageof 1

Frequent Collaborators

3 joint publications

Pieter Sonneveld

2 joint publications

Mathijs Arnoud Sanders

2 joint publications

Vincent H J van der Velden

2 joint publications

Cathelijne Fokkema